Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
Alkermes plc (Nasdaq: ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with idiopathic ...
American Association of Individual Investors33m
Which Is a Better Investment, Jazz Pharmaceuticals plc or Viatris Inc. Stock?
Learn more about whether Jazz Pharmaceuticals plc or Viatris Inc. is a better investment based on AAII's A+ Investor grades, ...
American Association of Individual Investors25m
Which Is a Better Investment, Jazz Pharmaceuticals plc or Novo Nordisk A/S Stock?
Learn more about whether Jazz Pharmaceuticals plc or Novo Nordisk A/S is a better investment based on AAII's A+ Investor ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Sei Investments Co. Has $7.54 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Sei Investments Co. decreased its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 30.5% in the 4th quarter, ...